News Archive - Miles Martin

Medicare is Overpaying for Generic Drugs

Researchers from the University of California San Diego, West Health, and the University of Washington have found evidence that the private insurers that sponsor Medicare Part D are artificially inflating the costs of certain generic drugs by overpaying pharmacies.

Breaking Down Barriers: What Happens When the Vaginal Microbiome Attacks

New findings from researchers at University of California San Diego shed light on why bacterial vaginosis, a common and seemingly benign condition of the vaginal microbiome, is linked to pregnancy loss, preterm birth and other health complications.

Introducing EUGENe: An Easy-to-Use Deep Learning Genomics Software

Researchers from UC San Diego have developed an easily-implemented toolkit for genomics researchers that simplifies the process of analyzing data with deep learning, a type of artificial intelligence capable of improving itself with limited user input.

New Studies of Brain Activity Explain Benefits of Electroconvulsive Therapy

Researchers from UC San Diego have shed new light on why electroconvulsive therapy has such a high success rate, a mystery that has puzzled doctors and scientists for almost a century. Findings could help improve this controversial treatment.

New Cancer Therapy Target Stops Tumor Cells From Sharing Resources

Researchers at University of California San Diego have discovered a process in which liver cells share molecules in order to multiply under conditions that would ordinarily suppress cell proliferation. They also found evidence that this process occurs in various types of cancer cells.

New Biomarker Predicts Whether Neurons Will Regenerate

Researchers from University of California San Diego have identified a new biomarker that can predict whether or not neurons will regenerate after an injury. The findings could help scientists develop regenerative therapies for spinal cord injuries and other neurological conditions.

Human Brain Cell Atlas Offers Unprecedented Look at Neuropsychiatric Disorders

In a large, multi-institutional effort led by University of California San Diego, researchers have analyzed more than a million human brain cells and revealed links between specific types of cells and various common neuropsychiatric disorders.

Cellular Atlas of Amygdala Reveals New Treatment Target for Cocaine Addiction

Researchers at University of California San Diego School of Medicine have used single-cell sequencing to identify a potential new treatment for cocaine addiction and shed new light on the molecular underpinnings of addiction.

UC San Diego Awarded $9.5 Million to Enhance Cybersecurity in Health Care

Researchers at University of California San Diego have been awarded $9.5 million from the Advanced Research Projects Agency for Health to develop better ways to prevent and mitigate ransomware attacks.

Intermittent Fasting Improves Alzheimer’s Pathology

New results from researchers at UC San Diego School of Medicine suggest that intermittent fasting could be an effective treatment approach for Alzheimer’s disease. Mice fed on a time-restricted schedule had better memory and less accumulation of amyloid proteins in the brain compared to controls.